Additionally, gain-of-function mutations in proprotein convertase subtilisin/kexin type 9 (PCSK9), an enzyme that mediates LDL-C receptor degradation, resulting in very high LDL-C levels, are also an etiology for FH [23]. This evidence concerns the gene PCSK9 and familial hyperaldosteronism.